NGFR and melanoma: Using surgically removed human tumors combined with an advanced techniques of cell isolation these studies demonstrated that CD271+ melanoma cells have increased tumor-initiating capacity, self-renew and can serially transplant the disease in-vivo recapitulating original patient tumor morphology and heterogeneity giving rise to CD271+ and CD271− cells9,10.